Skip to content

Study of Low Level Laser Therapy for Body Contouring

A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia ML Scanner (MLS) on Body Contouring of the Waist, Hips and Thighs Clinical Study Protocol

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00738426
Enrollment
72
Registered
2008-08-20
Start date
2007-10-31
Completion date
2008-07-31
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Contouring

Keywords

non-invasive body contouring of waists hips and thighs

Brief summary

The purpose of this study is to determine whether green diode low level laser therapy is effective for body contouring of the waist, hips and thighs.

Detailed description

Weight loss and body contouring are large, constantly-growing fields of cosmetic surgery. According to the American Society of Plastic Surgeons (ASPS) statistics, more than 324,000 liposuction procedures, 233,000 eyelid surgeries and 114,000 facelift procedures were performed in 2004 in the United States alone. However, while the demand for body shaping procedures is constantly on the rise, so is the demand for such procedures to be performed more quickly, simply and most importantly, less invasively. Cosmetic surgery patients are no longer satisfied with procedures that require general anesthesia, pose a multitude of potentially serious risks and complications and that require several weeks of recovery time. Hence the growing popularity of non- to minimally-invasive cosmetic surgery procedures. In 2005, more than 7.5 million minimally-invasive cosmetic procedures were performed, a 35% increase from 2000. Consequently, patients and physicians alike are continually searching for non-invasive alternatives to traditional cosmetic procedures such as liposuction that are efficient, safe and effective.

Interventions

Red diode low level laser light energy.

DEVICESham device

non-therapeutic light energy output

Sponsors

Erchonia Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* indicated for liposuction for the removal of localized deposits of adipose tissues that do not respond to diet and exercise; specifically in the areas of the waist, hips and bilateral thighs. * willing and able to abstain from partaking in any treatment other than the study procedure (existing or new) to promote body contouring and/or weight loss during the course of study participation. * willing and able to maintain regular diet and exercise regimen without during study participation. * 18 to 65 years. * Male or female.

Exclusion criteria

* Body Mass Index (BMI) of 30 kg/m² or greater. * Diabetes dependent on insulin or oral hypoglycemic medications. * known cardiovascular disease. * cardiac surgeries, pacemakers. * excessive alcohol consumption. * prior surgical intervention for body sculpting/weight loss. * medical, physical, or other contraindications for body sculpting/weight loss. * current use of medication(s) known to affect weight levels and/or to cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent. * medical condition known to affect weight levels and/or to cause bloating or swelling. * diagnosis of, and/or taking medication for, irritable bowel syndrome. * active infection, wound or other external trauma to the areas to be treated with the laser. * pregnant, breast feeding, or planning pregnancy prior to study end. * serious mental health illness; psychiatric hospitalization in past two years. * developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements. * involvement in litigation and/or a worker's compensation claim and/or receiving disability benefits related to weight-related and/or body shape issues. * participation in research in the past 90 days.

Design outcomes

Primary

MeasureTime frame
Incidence of the Reduction of at Least 3.0 Inches Off Their Combined Waist-hips-thighs Circumference.2 weeks

Countries

United States

Participant flow

Participants by arm

ArmCount
Erchonia ML Scanner (MLS)
Red diode low level laser light energy Erchonia ML Scanner (MLS): Red diode low level laser light energy.
35
Sham Device
non-therapeutic sham light output Sham device: non-therapeutic light energy output
32
Total67

Baseline characteristics

CharacteristicSham DeviceTotalErchonia ML Scanner (MLS)
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
32 Participants67 Participants35 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants1 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
32 Participants66 Participants34 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Region of Enrollment
United States
32 participants67 participants35 participants
Sex: Female, Male
Female
31 Participants64 Participants33 Participants
Sex: Female, Male
Male
1 Participants3 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 350 / 32
serious
Total, serious adverse events
0 / 350 / 32

Outcome results

Primary

Incidence of the Reduction of at Least 3.0 Inches Off Their Combined Waist-hips-thighs Circumference.

Time frame: 2 weeks

ArmMeasureValue (NUMBER)
Erchonia ML Scanner (MLS)Incidence of the Reduction of at Least 3.0 Inches Off Their Combined Waist-hips-thighs Circumference.21 participants
Sham DeviceIncidence of the Reduction of at Least 3.0 Inches Off Their Combined Waist-hips-thighs Circumference.2 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026